Compare Healthpeak Properties Inc. Common Stock (DOC) vs Lam Research Corporation (LRCX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Healthpeak Properties Inc. Common Stock vs Lam Research Corporation — how do they compare? Healthpeak Properties Inc. Common Stock trades at $18.55 (market cap $12.77B), while Lam Research Corporation trades at $326.54 (market cap $401.19B). The key difference: Lam Research Corporation is far larger — about 31.4× Healthpeak Properties Inc. Common Stock's market cap, and Healthpeak Properties Inc. Common Stock pays the higher dividend (6.59%). Which is the better fit depends on your goals — on Pluang, investors hold Healthpeak Properties Inc. Common Stock for 0 Days and Lam Research Corporation for 60 Days on average.
| DOC | LRCX | |
|---|---|---|
Market Cap | $12.77B | $401.19B |
Volume | 11,021,809 | 8,960,892 |
Sector | Real Estate | Technology |
52-Week High | $22.82 | $433.33 |
52-Week Low | $15.78 | $131.37 |
Typical Hold Time | 0 Days | 60 Days |
Enterprise Value | $21.46B | $399.35B |
Dividend Yield | 6.59% | 0.41% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Lam Research (LRCX) trades at $329.51, down 1.31% on the day, amid a bullish technical setup with strong support at $326 and resistance at $332. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $1.82 exceeding the $1.69 estimate. Revenue growth accelerated to $18.44B in 2025, driving a net income margin of 31.27%. Analyst sentiment remains overwhelmingly positive, with 78% recommending Buy and a consensus price target of $375.68, suggesting significant upside potential from current levels.
LRCX is well-positioned to capitalize on AI-driven demand for semiconductor equipment, supported by expanding margins and strong cash flow. However, elevated valuation multiples (P/E of 57.21) and exposure to cyclical chip industry downturns pose risks. The stock offers growth appeal for investors bullish on sustained tech capex, but requires monitoring of competitive pressures and macroeconomic headwinds that could impact equipment spending.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Healthpeak Properties Inc. Common Stock
Healthpeak Properties is a healthcare real estate investment trust in the United States. It owns, operates, and develops outpatient medical, laboratory, and senior housing properties.
Read more on DOC →About Lam Research Corporation
Lam Research manufactures equipment used to fabricate semiconductors. The firm is focused on the etching, deposition, and clean markets, which are key steps in the semiconductor manufacturing process, especially for 3D NAND flash storage, advanced DRAM, and leading-edge logic/foundry chipmakers. Lam's flagship Kiyo, Vector, and Sabre products are sold in all major geographies to key customers such as Samsung Electronics, Micron, Intel, and Taiwan Semiconductor Manufacturing.
Read more on LRCX →
